Gaithersburg-based Oncor Inc., which develops and makes gene-based tests for detecting cancer, announced yesterday that it has expanded its board of directors to eight members by naming two new directors.
The new directors are Jose Coronas, 54, and Dr. Derace Schaffer, 49.
Coronas is the former president of Johnson & Johnson Clinical Diagnostics Inc. He has also worked for the Clinical Diagnostics Division of the Eastman Kodak Co.
Schaffer is a clinical professor of radiology at the University of Rochester School of Medicine, and president of Ide Group P.C., a group medical practice in New York.
Also yesterday, Oncor said that earlier last month it began expanding the overseas marketing of its gene-based test for breast cancer, known as the HER-2/neu Gene Amplification Test.
The company has launched the marketing of the test in Spain, Portugal and Sweden.
The test, which is meant to be used to detect the recurrence of breast cancer, had previously been sold in nine countries, including Australia, Ireland and Britain.
Pub Date: 1/01/97
